JPRN-jRCTs042220045
Recruiting
Phase 3
Accuracy of quantification of myocardial blood flow by Dynamic Stress Perfusion CT: verification with 15O-H2O PET - ACCEPTOP trial
Ichikawa Yasutaka0 sites47 target enrollmentJuly 15, 2022
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Known or suspected chronic coronary artery disease
- Sponsor
- Ichikawa Yasutaka
- Enrollment
- 47
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\) Patients with known or suspected chronic coronary artery disease who are clinically indicated to be evaluated by myocardial perfusion imaging
- •2\) Age 50\-75
- •3\) Patients who have given written consent to perform 15O\-H2O myocardial perfusion PET and to participate in the study
Exclusion Criteria
- •1\) Contraindications to adenosine triphosphate and iodine contrast media
- •2\) Claustrophobia that makes it difficult to perform cardiac PET and CT examinations
- •3\) Difficulty with breath holding required for the cardiac PET and CT examinations
- •4\) Poor general condition
- •5\) Women with known or possible pregnancy
- •6\) Inappropriate research participants (judged by the researchers in this study)
- •7\) Patients who experienced a cardiovascular event, underwent revascularization, or had a change or addition of medication between cardiac CT and myocardial perfusion PET examinations
- •8\) Reduced renal function (determined as eGFR less than 0\.45 mL/min/1\.73m2 within 1 month before the examinations)
- •9\) A past history of myocardial infarction
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, Not Recruiting
Phase 1
Absolute quantification of myocardial blood flow in human subjects with SYN2 dynamic PET imagingCoronary Artery DiseaseMedDRA version: 20.0Level: PTClassification code: 10011078Term: Coronary artery disease Class: 100000004849Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14]CTIS2023-507520-23-00Synektik S.A.30
Active, Not Recruiting
N/A
Quantitative Assessment of Myocardial Perfusion with Magnetic Resonance Using an Intravascular Contrast AgentIschemic cardiomyopathy, with inducible ischemia and clinical indication to cardiac revascularizationMedDRA version: 9.1Level: LLTClassification code 10055217Term: Ischemic cardiomyopathyEUCTR2008-004895-39-GBKing's College London
Completed
N/A
Myocardial perfusion with an intravascular contrast agentCoronary artery diseaseCirculatory SystemChronic ischaemic heart diseaseISRCTN53688797King's College London (UK)156
Active, Not Recruiting
N/A
To evaluate the accuracy of functioning of heart using two different methods namely Electrical Cardiometry and Arterial pressure used during the operation under general anaesthesiaHealth Condition 1: C00-D49- NeoplasmsCTRI/2019/08/020543A
Completed
N/A
Diagnostic accuracy of quantitative vascular analysis (Syngo QVA) to assess the degree of stenosis of peripheral vessel lesions compared to other examination modalitiesI70.2Atherosclerosis of arteries of extremitiesDRKS00014192niversitätsklinikum Heidelberg103